Congress and the rest of the federal government must increase transparency for taxpayers
The New Year Is a New Chance to Restore Fiscal Sanity
Congress should resolve to pass policies that are fiscally responsible and alleviate the effects of inflation.
Build Back Better Act Will Destroy Vibrant U.S. Pharmaceutical Industry
CAGW’s latest report “Price Controls on Pharmaceuticals Are Bad Medicine,” analyzes destructive policies in the BBBA.
Three Reforms States Should Consider After the COVID-19 Pandemic
States should reform how they raise revenue, plan better for the future, and relax workforce regulations.
Congress Should Listen to Voters and Reject Drug Price Controls
A message was sent by voters in Virginia, New Jersey, and New York last night. Is Congress listening?
Price Controls Must Not Be Included in Reconciliation
The Biden administration and congressional leaders aim to implement price controls on healthcare.
Will Michigan’s State Legislators Micromanage PBMs?
Interfering in private contracts between pharmacy benefit managers and their customers will drive drug costs up, not down.
No Government Price Controls to Pay for Biden’s Gargantuan Spending Bill
Sen. Ron Wyden (D-Ore.) wants to use price controls in Medicare Part D to pay for President Biden’s extravagant spending.
Easing Occupational Licensing Restrictions will help Americans Overcome Barriers to Employment
Removing occupational licensing barriers at the federal level provides more freedom to states to reduce requirements
All Nations Must Respect and Protect Intellectual Property Rights
World Intellectual Property (IP) Day is a good time to remind all countries of the need to protect and respect IP rights.